Patents by Inventor Alix Berton

Alix Berton has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20190359701
    Abstract: This invention generally relates to methods for the treatment of respiratory diseases, such as asthma, utilizing anti-IL-23A antibodies.
    Type: Application
    Filed: March 8, 2019
    Publication date: November 28, 2019
    Applicant: Boehringer Ingelheim International GmbH
    Inventors: Kirsten ARNDT-SCHMITZ, Alix BERTON, Michael Chadham NIVENS, Karsten QUAST, Marco SCHLEPUETZ, Sudha VISVANATHAN
  • Publication number: 20180334501
    Abstract: This invention generally relates to methods for the treatment of respiratory diseases, such as asthma, utilizing anti-IL-23A antibodies.
    Type: Application
    Filed: June 27, 2018
    Publication date: November 22, 2018
    Applicant: Boehringer Ingelheim International GmbH
    Inventors: Kirsten Arndt-Schmitz, Alix Berton, Michael Chadham Nivens, Karsten Quast, Marco Schlepuetz, Sudha Visvanathan
  • Publication number: 20180009887
    Abstract: This invention generally relates to methods for the treatment of respiratory diseases, such as asthma, utilizing anti-IL-23A antibodies.
    Type: Application
    Filed: August 25, 2017
    Publication date: January 11, 2018
    Applicant: Boehringer Ingelheim International GmbH
    Inventors: Kirsten Arndt-Schmitz, Alix Berton, Michael Chadham Nivens, Karsten Quast, Marco Schlepuetz, Sudha Visvanathan
  • Publication number: 20160304602
    Abstract: This invention generally relates to methods for the treatment of respiratory diseases, such as asthma, utilizing anti-IL-23A antibodies.
    Type: Application
    Filed: April 13, 2016
    Publication date: October 20, 2016
    Inventors: Kirsten ARNDT, Alix BERTON, Michael Chadham NIVENS, Karsten QUAST, Marco SCHLEPUETZ, Sudha VISVANATHAN
  • Patent number: 8425878
    Abstract: The present invention is directed to the identification of a biomarker specifically located in the plasma membrane of pancreatic beta cells. It was selected by a Systems Biology approach on Massively Parallel Signal Sequencing datasets obtained in human islets and Affymetrix microarray datasets on human islets, purified rat primary beta and non beta cells and insulinoma cells. Based on a set of specific features the biomarker is a unique candidate for imaging and targeting strategies to study the pancreatic beta cell mass in health and disease (T1 D, T2D, pancreatic cancers, obesity, islet transplantation, beta cell regeneration).
    Type: Grant
    Filed: February 13, 2009
    Date of Patent: April 23, 2013
    Assignee: Universite Libre de Bruxelles
    Inventors: Decio L. Eizirik, Daisy Flamez, Isabelle Salmon, Alix Berton, Isabelle Roland, Daniel Marechal, Marie-Claire Beckers, Leroy Hood, Nathan Goodman, Burak Kutlu
  • Publication number: 20100322850
    Abstract: The present invention is directed to the identification of a biomarker specifically located in the plasma membrane of pancreatic beta cells. It was selected by a Systems Biology approach on Massively Parallel Signal Sequencing datasets obtained in human islets and Affymetrix microarray datasets on human islets, purified rat primary beta and non beta cells and insulinoma cells. Based on a set of specific features the biomarker is a unique candidate for imaging and targeting strategies to study the pancreatic beta cell mass in health and disease (T1 D, T2D, pancreatic cancers, obesity, islet transplantation, beta cell regeneration).
    Type: Application
    Filed: February 13, 2009
    Publication date: December 23, 2010
    Inventors: Decio L. Eizirik, Daisy Flamez, Isabelle Salmon, Alix Berton, Isabelle Roland, Daniel Marechal, Marie-Claire Beckers, Leroy Hood, Nathan Goodman, Burak Kutlu